Exciting times ahead.
Trofinetide action over the next 10 months will be huge - 10 months of action ahead of us there.
- and NNZ2591 is even more promising and is a "superior drug" according to Jon.
And we currently own 100% of NNZ2591.
Treatment for all of these ailments using Neuren's drugs will be a fantastic achievement.
In my opinion this company is cashed up and substantially de-risked.
Neuren will get a lot of interest over the next 12-18 months.
Exciting times ahead.Trofinetide action over the next 10 months...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 3429 | 4 |
View Market Depth
| Last trade - 16.16pm 08/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable